Duloxetine HCL DR Capsules

PresolicitationActive

Puntos Clave

  • No se especificó fecha límite de respuesta - contacte a la agencia para detalles
  • Competencia abierta completa - todas las empresas pueden participar
  • Trabajo a realizarse en PHILADELPHIA, PA
  • Industria: Pharmaceutical Preparation Manufacturing

Detalles del Contrato

ID de Aviso
SPE2D219R0052
Tipo de Oportunidad
Presolicitation
Sub-Agencia
DEFENSE LOGISTICS AGENCY
Oficina
DLA TROOP SUPPORT
Fecha de Publicación
Tuesday, December 3, 2019
Fecha Límite de Respuesta
No especificado
Código PSC
6505
Reserva
Competencia Abierta Completa
Lugar de Desempeño
PHILADELPHIA, PA, 19111
Estado
Activo

Descripción

Correcting Duloxetine HCL DR to reflect capsules i/l/o tablets. The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.Duloxetine HCL DR Capsules 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indi

Por Qué Importa Esta Oportunidad

The Department of DEFENSE está buscando activamente contratistas calificados para pharmaceutical preparation manufacturing en PHILADELPHIA, PA.